Dawes Karen A's Form 4 filing
Barinthus Biotherapeutics plc. (BRNS) · filed Sep 9, 2026
- Accession no.
- 0001104659-26-106323
- Filed
- Sep 9, 2026, 4:15 PM ET
- Trade date
- Sep 9, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 5 derivative transactions. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dawes Karen ACIK 0001261506 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Ordinary Shares | DReturned to the companyDisposed | −1,700 | – | – | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Ordinary Shares | DReturned to the companyDisposed | −34,328 | $0.00 | $0 | 0 | Direct | |
| Sep 9, 2026 | Ordinary Shares | DReturned to the companyDisposed | −18,604 | $0.00 | $0 | 0 | Direct | |
| Sep 9, 2026 | Ordinary Shares | DReturned to the companyDisposed | −19,197 | $0.00 | $0 | 0 | Direct | |
| Sep 9, 2026 | Ordinary Shares | DReturned to the companyDisposed | −19,516 | $0.00 | $0 | 0 | Direct | |
| Sep 9, 2026 | Ordinary Shares | DReturned to the companyDisposed | −20,174 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.